Intimation of Investor meet.

Board & Shareholder Meetings View source PDF

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Aurobindo Pharma has informed stock exchanges that its officials will participate in the B&K 15th Annual Investor Conference – TRINITY INDIA 2025 on May 30, 2025, from 8:00 AM to 8:00 PM IST in Mumbai. The meeting will be held in-person and through group interactions. The company has clarified that no unpublished price sensitive information (UPSI) will be discussed during the interactions. The schedule remains subject to change due to any last-minute exigencies.

Likely market impact

This is a routine corporate disclosure and is unlikely to have any direct impact on the stock price. It signals continued investor engagement by the company but involves no material or price-sensitive information.